JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Breuer, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breuer, J
J Clin Pathol 2001; 54:743-747
© 2001 Journal of Clinical Pathology


Leader

Vaccination to prevent varicella and shingles

J Breuer

Department of Virology, St Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, 37 Ashfield Street, London E1 1BB, UK

Dr Breuer j.breuer{at}mds.qmw.ac.uk Vaccination of healthy children against varicella using the live attenuated Oka vaccine has been available in Japan and south Korea for several years. In 1996, a programme of universal vaccination of children to prevent varicella was introduced in the USA and other countries, including Canada, Germany, and Sweden, have licensed the vaccine for use in healthy children. This article reviews the origin of the Oka vaccine and the evidence for vaccine safety and efficacy in children and adults. Universal vaccination of children and targeted vaccination of groups at risk of severe varicella are discussed. The possible use of the Oka vaccine to prevent zoster is reviewed, and initiatives to develop new varicella zoster virus vaccines are outlined.

Key Words: chickenpox • varicella zoster • herpes zoster • vaccination • leukaemia




This article has been cited by other articles:


Home page
CVIHome page
P. A. C. Maple, J. Gray, J. Breuer, G. Kafatos, S. Parker, and D. Brown
Performance of a Time-Resolved Fluorescence Immunoassay for Measuring Varicella-Zoster Virus Immunoglobulin G Levels in Adults and Comparison with Commercial Enzyme Immunoassays and Merck Glycoprotein Enzyme Immunoassay
Clin. Vaccine Immunol., February 1, 2006; 13(2): 214 - 218.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H Holzel
Grand Round Presentation
J. Clin. Pathol., July 1, 2002; 55(7): 487 - 487.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S J Katona and J Breuer
Vaccination to prevent varicella and shingles
J. Clin. Pathol., May 1, 2002; 55(5): 399 - 399.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.